About: Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.47 (-5.99%)
CRBU NASDAQ Caribou Biosciences Inc
Caribou Biosciences Inc share price
CRBU price activity
Last Price
$0.470
Change (24hr)
-0.03 USD (-5.99%)
Volume
2.92M
Volume (4w avg)
-
Open
$0.48
Day Range
$0.47 - $0.48
Previous Close
$0.50
Last Trade
13 Oct, 4:58 pm GMT+0
Delayed
13 Oct, 4:58 pm GMT+0
CRBU price performance
Delayed
13 Oct, 4:58 pm GMT+0
CRBU Market Signals